// App-Quantinova.ai

1109-119 : RELATIONSHIP BETWEEN DOSE, ANTI-FACTOR XA ACTIVITY, AND OUTCOMES IN PATIENTS RANDOMIZED TO EDOXABAN IN THE ENGAGE AF-TIMI 48 TRIAL

Researchers

Presenter

  • Christian T. Ruff

Principal Investigators

  • Robert Giugliano

  • Eugene Braunwald

  • David Morrow

  • Sabina Murphy

  • Naveen Deenadayalu

  • Petr Jarolim

  • Joshua Betcher

  • Minggao Shi

  • Karen S. Brown

  • Indravadan Patel

Medical Centers

  • N/A

Locations

  • N/A

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

Disease

  • Arrhythmia

  • Venous thrombosis

  • Stroke

Biomarkers

  • N/A

Drug/Treatment

  • Edoxaban

  • Warfarin

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved